| Danielle Steepe, PHARMD, RPH | |
|
4230 Don King Rd, Ketchikan, AK 99901-9047 | |
| (907) 247-2183 | |
| Not Available |
| Full Name | Danielle Steepe |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4230 Don King Rd, Ketchikan, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235693722 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 137445 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Danielle Steepe, PHARMD, RPH 4230 Don King Rd, Ketchikan, AK 99901-9047 Ph: () - | Danielle Steepe, PHARMD, RPH 4230 Don King Rd, Ketchikan, AK 99901-9047 Ph: (907) 247-2183 |
News Archive
Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
"Republican Senator Olympia Snowe says the Finance Committee's health care bill is a 'solid starting point' but needs to be improved," The Associated Press reports. "The Maine senator is seen as the only Republican on the panel who could end up voting for the bill, so her comments are closely watched." In her opening statement at the Finance Committee mark-up today, "Snowe praised the bill for holding down costs and taking a stab at medical malpractice reform.
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
A national sickle cell disease study involving Medical University of South Carolina researchers found that for some children with sickle cell disease, the drug hydroxyurea is as effective as blood transfusions to reduce blood flow speeds in the brain. Increased blood flows are a major risk factor for stroke in these children.
› Verified 3 days ago
Kalli Kline, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3526 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-6186 | |
Maxx Ritchie Keizer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 | |
Jacob Pignone, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2417 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-1960 Fax: 907-228-1919 | |
Kristin Frye, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4230 Don King Rd, Ketchikan, AK 99901 Phone: 907-247-2183 Fax: 907-247-2187 | |
Dr. Liliana B Boardman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 Fax: 907-228-5232 | |
Torrie Jayne Borch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3526 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-6186 |